Related Experiment Video
Updated: Sep 18, 2025

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
[Hereditary haemorrhagic telangeiectasia]
Kumanan Rune Nanthan1, Pernille Mathiesen Tørring2, Jens Kjeldsen3
1Øre- Næse- Halsafdelingen, Odense Universitetshospital.
Abstract:
Hereditary haemorrhagic telangeiectasia (HHT) is an autosomal dominant hereditary disease, which affects 15.6/100,000 people in Denmark. In this review, we summarize the current Danish practice on screening, diagnosis, treatment and outpatient control of HHT patients, put an emphasis on the importance of proper screening and treatment of HHT-associated anaemia, and address the latest addition of biological treatment and advances in genetic sequencing to be utilized in HHT.
Related Concept Videos
Genetic Lingo
Regulation of Angiogenesis and Blood Supply
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

